Overcoming cellular barriers for RNA therapeutics

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139

A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity

Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429

Multiplex Genome Engineering Using CRISPR/Cas Systems

Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456

RNA-Guided Human Genome Engineering via Cas9

Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781

Direct Gene Transfer into Mouse Muscle in Vivo

Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173

Mechanisms of endocytosis

Doherty, G. J., & McMahon, H. T. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.081307.110540 · Cited by 3,075

In vivo genome editing using Staphylococcus aureus Cas9

Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687

A dual-locked cyclopeptide–siRNA conjugate for tumor-specific gene silencing

Li, C., Sun, S., Kong, H., Xie, X., Liang, G., Zhang, Y., Wang, H., & Li, J. (2024) · RSC Chemical Biology · doi:10.1039/d4cb00247d · Cited by 3

Assessing the Cellular Uptake, Endosomal Escape, and Cytosolic Entry Efficiencies of Cyclic Peptides

Salim, H., & Pei, D. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1689-5_16 · Cited by 3

Methods for CPP Functionalization

Langel, Ü. (2019) · Springer eBooks · doi:10.1007/978-981-13-8747-0_3 · Cited by 3

Long Noncoding RNAs in Cardiovascular Disease

Holdt, L. M., Kohlmaier, A., & Teupser, D. (2019) · Cardiac and vascular biology · doi:10.1007/978-3-030-27371-2_7 · Cited by 3

Covalent binding of molecules to plasma immersion ion implantation‐activated microparticles for delivery into cells

Kruse, H. V., Tran, C., van Zandwijk, N., Suchowerska, N., McKenzie, D. R., & Reid, G. (2020) · Engineering Reports · doi:10.1002/eng2.12087 · Cited by 3

In silico study of the binding of daunomycin and phenylalanine transfer RNA: probe molecular recognition for structure-based drug design

Wu, G., Li, J., Yang, J., & Xiao, X. (2023) · Molecular Systems Design & Engineering · doi:10.1039/d2me00236a · Cited by 3

mTOR Inhibition Enhances Delivery and Activity of Antisense Oligonucleotides in Uveal Melanoma Cells

Dewaele, S., Delhaye, L., Paepe, B. D., Bogaert, B., Martinez, R., Anckaert, J., Yigit, N., Nuytens, J., Coster, R. V., Eyckerman, S., et al. (2023) · Nucleic Acid Therapeutics · doi:10.1089/nat.2023.0008 · Cited by 3

Peptides as molecular Trojan horses

Yuan, P. (2022) · Nature Chemistry · doi:10.1038/s41557-022-00906-3 · Cited by 3

PROGRESS OF OLIGONUCLEOTIDE THERAPEUTICS TARGET TO RNA

Pan, Y., Zhou, X., & Yang, Z. (2022) · Wiley eBooks · doi:10.1002/9781119692799.ch11 · Cited by 3

Application of vinyl polymer‐based materials as nucleic acids carriers in cancer therapy

Pereira, P., Serra, M. E. S., Serra, A. C., & Coelho, J. F. J. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1820 · Cited by 2

Synthesis and evaluation of antisense oligonucleotides prodrug with G-quadruplex assembly and lysosome escape capabilities for oncotherapy

Chen, Z., Zhang, Z., Liu, S., Xiao, Z., Luo, Y., Pan, X., Feng, X., & Xu, L. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107475 · Cited by 2

The Usefulness of Determining Plasma and Tissue Concentrations of Phosphorodiamidate Morpholino Oligonucleotides to Estimate Their Efficacy in Duchenne Muscular Dystrophy Patients

Imai, S., Watanabe, N., Tone, Y., Mitamura, R., Mori, J., Kameyama, T., Yamada, T., & Kusano, K. (2024) · Drug Metabolism and Disposition · doi:10.1124/dmd.124.001806 · Cited by 2

Antisense Oligonucleotides (ASOs)

Tosar, J. P. (2024) · Topics in medicinal chemistry · doi:10.1007/7355_2024_170 · Cited by 2

The Road to RNAi-Based Pest Control: A Historical Perspective

Swevers, L., Palli, S. R., & Smagghe, G. J. (2025) · Springer eBooks · doi:10.1007/978-3-031-81549-2_1 · Cited by 2

Loading Proteins into Extracellular Vesicles to Camouflage Protein Allergens

Rao, E., Paterna, A., Longo, V., Aloi, N., Adamo, G., Picciotto, S., Romancino, D. P., Raccosta, S., Bongiovanni, A., Colombo, P., et al. (2025) · ACS Omega · doi:10.1021/acsomega.5c03419 · Cited by 2

NIR-mediated endosomal escape-enhanced STING-pyroptosis self-recycling amplification/FNAzymes cleavage for triple-negative breast cancer therapy

Liang, Y., An, R., Du, P., Liu, S., Wei, Y., Zheng, J., Lei, P., & Zhang, H. (2025) · Science China Chemistry · doi:10.1007/s11426-025-2936-7 · Cited by 2

Design strategies to optimize polymeric vectors for mRNA delivery

Turhan, Z. Y., Savaş, M., Alakbarov, A., & Bulmuş, V. (2025) · Journal of Macromolecular Science Part A · doi:10.1080/10601325.2025.2587806 · Cited by 2

Importance and Potential of Rare Disease Research in Pediatric Rheumatology and Beyond: Pushing Frontiers

Hedrich, C. M. (2025) · ACR Open Rheumatology · doi:10.1002/acr2.70138 · Cited by 2

Dual end-functionalisation of poly(beta-amino ester) gene delivery vectors using multicomponent chemistry

O'Shaughnessy, L., Khosravi, R., Robins, J., Anane-Adjei, A., Mazza, M., Hori, N., Gurnani, P., & Alexander, C. (2025) · RSC Applied Polymers · doi:10.1039/d5lp00251f · Cited by 4

miRNA Delivery Systems, Improvements, and Challenges

Tuteja, D., Yadav, A. K., Bhatia, D. D., & Kumar, A. (2026) · Springer eBooks · doi:10.1007/978-981-95-5989-3_9 · Cited by 2

A hepatic-targeted glycogen-based nano-platform enables efficient CTGF silencing and attenuates liver fibrosis

Gao, M., Wen, Z., Zhang, X., Guo, Z., & Jiang, Y. (2026) · Nanotechnology · doi:10.1088/1361-6528/ae435b · Cited by 2

Topical Delivery of CNP-miR146a via a Pluronic Lecithin Organogel Enhances Diabetic Wound Healing

Lyttle, B. D., Bardill, J. R., Vaughn, A. E., Apte, A., Agustin, A. S., Kolanthai, E., Seal, S., Jackson, D. M., Liechty, K. W., & Zgheib, C. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18020248 · Cited by 2

Calcium Shock Enables Efficient and Programmable Particle Delivery for Genome Editing Applications

Vo, N., de Oñate, L., Frank, M., Hu, X., Blackburn, S. M., Foss, D. V., Villegas, J., Asija, K., Hockemeyer, D. F., Fu, H., et al. (2026) · Advanced Science · doi:10.1002/advs.202510441 · Cited by 2

The m6A-circRNA axis: a therapeutic prospect for gastric cancer

Li, Z., Gu, Y., Gu, H., She, Q., & Tong, Y. (2026) · Cell Biology and Toxicology · doi:10.1007/s10565-026-10184-1 · Cited by 2

RNA Therapeutics in Viral Infections and Cancer: Mechanisms, Challenges, and Prospects: A Review

Generalov, E. A., Shevelev, A. B., Romanov, D., Tarasova, O. A., & Pozdniakova, N. V. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18040431 · Cited by 3

Promoter‐Targeting RNA Technologies: An Epigenetic Strategy for Gene Activation and Gene Silencing

Hegde, R., Ajees, M. A., Damodar, K. S. H., Poojary, E., Hegde, S., & Kabekkodu, S. P. (2026) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.70043 · Cited by 2

Progress in siRNA nucleic acid therapeutics and challenges in their application to cancer treatment

Ui‐Tei, K. (2026) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyag099 · Cited by 3

Design of Nanocarriers for Kidney Targeted Delivery of Nucleic Acid Therapeutics

Lee, J. H., Han, J., Park, S., & Mok, H. (2026) · Macromolecular Bioscience · doi:10.1002/mabi.70210 · Cited by 2

Nanomedicine Strategies to Ameliorate Neuroinflammation and Prevent Secondary Neural Tissue Damage

Hegab, R. A., & Peppas, N. A. (2026) · ACS Nano Medicine · doi:10.1021/acsnanomed.6c00120 · Cited by 2

Self-Healing Hydrogels as Biomedical Scaffolds for Cell, Gene and Drug Delivery

Yuan, W., & Wang, C. (2017) · Research & Reviews Journal of Material Sciences · doi:10.4172/2321-6212.1000191 · Cited by 2

Two-dimensional Ostwald ripening with irreversible absorption or reaction on boundaries

Zhdanov, V. P. (2019) · Physica A Statistical Mechanics and its Applications · doi:10.1016/j.physa.2019.122405 · Cited by 2

A diaminoethane motif bearing low molecular weight polymer as a new nucleic acid delivery agent

Zelçak, A., Unal, Y. C., Meşe, G., & Bulmuş, V. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102551 · Cited by 2

Gene Silencing Therapeutics in Cardiology: A Review Article

Jay, P. Y., Maier, M. A., Saltonstall, L., Duarte, L., Antonino, I., & Vest, J. (2021) · International Journal of Cardiovascular Sciences · doi:10.36660/ijcs.20200306 · Cited by 2

Aptamers and antisense oligonucleotide-based delivery

Yazdian, F. A., & Janghorbani, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91924-1.00012-5 · Cited by 2

Critical applications and prospects of RNA modification in mRNA vaccines

Liu, C., Peng, J., Zhang, M., Xiang, H., & Yi, C. (2024) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2023-0800 · Cited by 2

Programmable Circular Multivalent Nanobody‐Targeting Chimeras (mNbTACs) for Multireceptor‐Mediated Protein Degradation and Targeted Drug Delivery

Jiang, S., Lv, X., Ouyang, Z., Chi, H., Zeng, Y., Wang, Y., He, J., Chen, J., Chen, J., An, K., et al. (2024) · Angewandte Chemie · doi:10.1002/ange.202407986 · Cited by 2

Non-coding RNAs in thoracic disease: Barrett’s esophagus and esophageal adenocarcinoma

Sheng, S., Guo, J., Lu, C., & Hu, X. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120242 · Cited by 2

Tumor suppressor protein-inspired peptide for siRNA delivery and synergistic cancer therapy

Essola, J. M., Yang, H., Liu, W., Hussain, A., Naeem, A., He, H., Barth, S., Wang, Z., Fan, K., Zhang, M., et al. (2025) · Fundamental Research · doi:10.1016/j.fmre.2025.03.006 · Cited by 2

A4GALT-targeting siRNA lipid nanoparticles ameliorate Fabry disease phenotype: Greater efficacy in endothelial cells than in podocytes

Shin, Y., Lee, H., Fang, X., Cui, S., Lim, S. W., Lee, K. I., Lee, J. Y., Kim, H. L., Oh, Y., Li, C., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102573 · Cited by 2

The impact of METTL3 on bladder cancer through m6A modification: a potential therapeutic target and prognostic biomarker

Wen, D., Fu, P., Shuai, G., Wang, Y., Yu, S., Liu, H., Wan, W. K., Zou, J., & Zou, X. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1622117 · Cited by 2

Opportunities and Challenges in Targeted Carrier-Based Intracellular Drug Delivery: Increased Efficacy and Reduced Toxicity

Dhoble, S., Dhage, S. N., Pulakkat, S., & Patravale, V. B. (2019) · Springer eBooks · doi:10.1007/978-981-13-3642-3_12 · Cited by 2

Slow relaxation during and after perturbation of bistable kinetics of gene expression

Zhdanov, V. P. (2019) · European Biophysics Journal · doi:10.1007/s00249-019-01358-3 · Cited by 2

Emerging CRISPR/Cas9 applications for T-cell gene editing

Preece, R., & Georgiadis, C. (2019) · Emerging Topics in Life Sciences · doi:10.1042/etls20180144 · Cited by 2

Synthesis of siRNAs incorporated with cationic peptides R8G7 and R8A7 and the effect of the modifications on siRNA properties

Matsubara, M., Honda, K., Ozaki, K., Kajino, R., Kakisawa, Y., Maeda, Y., & Ueno, Y. (2020) · RSC Advances · doi:10.1039/d0ra05919f · Cited by 2

Nanosized Particles Assembled by a Recombinant Virus Protein Are Able to Encapsulate Negatively Charged Molecules and Structured RNA

Mani, H., Chen, Y.-C., Chen, Y.-K., Liu, W., Lo, S., Lin, S.-H., & Liou, J.-W. (2021) · Polymers · doi:10.3390/polym13060858 · Cited by 2

MicroRNAs Involved in Small-cell Lung Cancer as Possible Agents for Treatment and Identification of New Targets

Weidle, U. H., & Nopora, A. (2021) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20283 · Cited by 2

Development of RNA-Based Medicine for Colorectal Cancer: Current Scenario

Amit, A., Yadav, S., Singh, R. P., & Kumar, C. (2022) · Springer eBooks · doi:10.1007/978-3-030-72702-4_16 · Cited by 2

Toward the therapeutic application of small interfering RNA bioconjugates in the central nervous system

Cortinhas, J., Pêgo, A. P., & Moreno, P. M. D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818084-6.00009-x · Cited by 2

Polymeric micelles for drug delivery in oncology with an emphasis on siRNA conveyance

Marquet, F., & Borchard, G. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89868-3.00014-8 · Cited by 2

Rapid and dynamic nucleic acid hybridization enables enzymatic oligonucleotide synthesis by cyclic reversible termination

Hoff, K., Halpain, M., Garbagnati, G., Edwards, J., & Zhou, W. (2019) · doi:10.1101/561092 · Cited by 2

Biomaterials for Advanced Personalized Therapeutic Approaches

Rai, A., Mitra, A., Chatterjee, N., Kumar, P., Malik, S., Kumar, V., & Misra, S. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820352-1.00096-1 · Cited by 2

DNA/RNA heteroduplex oligonucleotides: An unanticipated twist in the delivery of ASOs

Setten, R. L., & Dowdy, S. F. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.06.013 · Cited by 2

Self-delivering CRISPR RNAs for AAV Co-delivery and Genome Editing in vivoPreprint

Zhang, H., Kelly, K. L., Lee, J., Echeverria, D., Cooper, D., Panwala, R., Chen, Z., Gaston, N., Newby, G. A., Xie, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.20.533459 · Cited by 2

RNA therapeutics for the treatment of blood disorders

Ngo, A. D., Nguyen, H. L., Çağlayan, Ş., & Chu, D. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.11.005 · Cited by 1

An Amphiphilic Cell‐Penetrating Macrocycle for Efficient Cytosolic Delivery of Proteins, DNA, and CRISPR Cas9

Qutub, S., Bhat, I. A., Maatouk, B. I., Moosa, B., Fakim, A., Nawaz, K., Díaz‐Galicia, E., Lin, W., Grünberg, R., Arold, S. T., et al. (2024) · Angewandte Chemie · doi:10.1002/ange.202403647 · Cited by 1

Manual and automated synthesis of modified oligonucleotides on core–shell solid supports

Menéndez-Méndez, L. M., Fàbrega, C., Aviñó, A. M., Eritja, R., Lee, Y., Sanghvi, Y. S., Fernández, S., & Ferrero, M. (2024) · Results in Chemistry · doi:10.1016/j.rechem.2024.101930 · Cited by 1

Small Interfering RNAs (siRNAs)

Tosar, J. P. (2024) · Topics in Medicinal Chemistry · doi:10.1007/7355_2024_171 · Cited by 1

Application of small interfering RNA technology in cytochrome P450 gene modulation

Jiang, W., Sang, R., Zhang, C., Yin, R., Ouyang, Z., & Yuan, W. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100040 · Cited by 1

Complicated crosstalk between HMGA and non-coding RNAs modulates hallmarks of cancer

Zhang, L., Zhao, X., Gao, X., Qin, H., Chen, F., & Lin, Z. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03713-1 · Cited by 1

Self‐Assembled Multilayered Concentric Supraparticle Architecture

Suresh, A., Suresh, D., Li, Z., Sansalone, J., Aluru, N. R., Upendran, A., & Kannan, R. (2025) · Advanced Materials · doi:10.1002/adma.202502055 · Cited by 1

Efficient Cytosolic Delivery of siRNA Using Lyophilized and Reconstituted Polymer-siRNA Polyplexes

Nagaraj, H., Jeon, T., Çiçek, Y. A., Goswami, R., Nasim, N., Mhaske, R., & Rotello, V. M. (2025) · Pharmaceutical Research · doi:10.1007/s11095-025-03884-6 · Cited by 1

RNA Therapeutics: Bridging Discovery and Clinical Implementation

Sioud, M. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4742-4_1 · Cited by 1

Lipid Nanoparticle Co‐Delivery of mRNA and a Small Molecule Drug for Oral Cancer Chemoimmunotherapy

Padilla, M. S., Li, J. J., Zhang, Q., Patwari, K., Shi, S., Yamagata, H. M., Joseph, R. A., Hymms, B. N., Teerdhala, S. V., Fitzgerald, E., et al. (2026) · Advanced Materials · doi:10.1002/adma.73721 · Cited by 1

The crosstalk between MiRNAs and autophagy in leukemia: mechanisms and therapeutic insights

Beyrami, A. F., Akbari, A. A. M., Maleki, L. A., Dolati, S., & Yousefi, M. (2025) · Discover Oncology · doi:10.1007/s12672-025-03686-7 · Cited by 2

Nano/micro-scale targeted RNA delivery systems for cancer therapy

Li, X.-B., Liu, J., Chen, Y., Zhang, J., Li, J., Wagner, E., & Zhang, C. Y. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126451 · Cited by 1

FAST‐CRISPR: Fusogenic Association and Secured Transfection of CRISPR/Cas9 Ribonucleoproteins Using Lipid‐Silica Hybrid Nanoparticles for Therapeutic Genome Editing

Kim, M., Kim, K., Lee, J., Lee, S. H., Choi, S., Park, S. A., Jeong, E., Choi, S., Park, H. H., Park, T., et al. (2026) · Small · doi:10.1002/smll.202511362 · Cited by 2

Precision nanomedicine in cardiovascular disease: Engineered siRNA delivery platforms for atherosclerosis and ischemic heart disease

Lu, H., Huang, Q., Xiong, Z., Wu, C., Ren, S., Wang, X., & Shi, J. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.172968 · Cited by 2

Monodisperse mRNA-Loaded Lipid Nanoparticles Enabled by Optimizing an Ionizable Cationic Lipid

Toyoda, Y., Miyazaki, Y., Tsuda, S., Yamamura, H., Shimada, N., & Akiba, I. (2026) · Langmuir · doi:10.1021/acs.langmuir.5c05504 · Cited by 1

Structural Dynamics of Peptiplexes Formed between Cationic Cell-Penetrating Peptides and DNA: A Comparative Study on TAT-HIV and NLS-SV40T

de Mello, L. R., Siddiq, I. A., Garcia, B. B. M., Hamley, I. W., Riske, K. A., Han, S. W., Tresset, G., Lansac, Y., Jang, Y. H., & da Silva, E. R. (2026) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c01567 · Cited by 1

Dual centrifugation – a novel perspective on lipid nanoparticle formulation development

Bender, V., Fuchs, L. Y., Köll-Weber, M., Lembeck, J., Kaul, L., Süss, R., & Massing, U. (2026) · RSC Pharmaceutics · doi:10.1039/d5pm00287g · Cited by 1

Non-coding RNAs in gene therapy: mechanisms, delivery strategies, and clinical translation

Abuhaliema, A., Gharaibeh, L., Jaradat, E., Hammad, M., & Alshaer, W. (2026) · Pharmacia · doi:10.3897/pharmacia.73.e173259 · Cited by 1

Nucleic Acid Nanodevices for siRNA Delivery

Sun, M., Ding, Y., & Chao, J. (2026) · ACS Nano Medicine · doi:10.1021/acsnanomed.5c00196 · Cited by 1

MicroRNAs in kidney fibrosis: A review from molecular insights to therapeutic frontiers

Samad, A. F. A., Chiu, C., Kamaroddin, M. F., & Guerrero, J. J. G. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151466 · Cited by 1

Machine Learning–Driven QSAR Modeling for pKa Prediction of Ionizable Lipids in Lipid Nanoparticles for Hepatic Gene Silencing

Kongtaworn, N., Toopradab, B., Todsaporn, D., Tinpovong, P., Thongsuebsaeng, R., Maitarad, P., & Rungrotmongkol, T. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27094075 · Cited by 2

From edits to Circuits: Nucleic acid therapeutics for Correcting human disease

Guinn, M. T., Sinenko, I., Ghanta, R. K., & Omid Veiseh, A. (2026) · Materials Today · doi:10.1016/j.mattod.2026.103351 · Cited by 1

Injectable pre-vascularized alginate-collagen hydrogel with sustained delivery of miR-133a-loaded lipid nanoparticles for myocardial repair

Gil-Cabrerizo, P., Simón‐Yarza, T., Imaz, A. M., Lugli, E., Paredes, J., Aldazabal, J., Garbayo, E., & Blanco‐Prieto, M. J. (2026) · Drug Delivery and Translational Research · doi:10.1007/s13346-026-02167-w · Cited by 1

Exploring the functional role of XIST in breast cancer from mechanisms to clinical implications

Zyada, N. I., KAMEL, M. M., Elzayat, E. M., & Wahab, A. H. A. A. (2026) · Discover Oncology · doi:10.1007/s12672-026-04978-2 · Cited by 1

Exploring Clearance Pathways for GalNAc–siRNAs: Insights into Intracellular Kinetics and Therapeutic Implications

Tompach, M. C., Craig, K., & De, S. (2026) · Nucleic Acid Therapeutics · doi:10.1177/21593337261457402 · Cited by 1

The Use of Deep Learning in RNA Therapeutic Development

Subramanian, D. A., Yao, S. L., Chan, A., Witten, J. J., Reker, D., Anderson, D. G., Langer, R., & Traverso, G. (2026) · ACS Nano · doi:10.1021/acsnano.6c02090 · Cited by 1

Accelerating drug discovery with mass spectrometry-driven bioanalytical innovations and beyond

Mwangi, J. N., Hill, R. C., Runnebohm, A. M., Czerwieniec, G. A., & Berna, M. J. (2026) · Bioanalysis · doi:10.1080/17576180.2026.2687591 · Cited by 1

Survivin-Targeting Antisense Oligonucleotides in Cancer Therapy

Poudel, B. H., Chen, S., & Veedu, R. N. (2026) · Molecules · doi:10.3390/molecules31132283 · Cited by 1

Biomacromolecule–MOF Composites for Intracellular Delivery: From Empirical Construction to Rational Design and AI‐Assisted Screening

Xu, L., Yu, H., Li, X. Y., & Ge, J. (2026) · Small · doi:10.1002/smll.74697 · Cited by 1

From PEG to randomized PEG: a macromolecular strategy tackling PEG immunogenicity

Schmidt, J., Bockhard, C., Simon, L., Linden, G. M., Scheiger, J. M., & Frey, H. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115943 · Cited by 3

Metal–Organic Frameworks (MOFs) for the Delivery of Small-Molecule Therapeutics

Tong, P., Hu, X., Yan, K., Yuan, X., James, T. D., Wang, H., & He, X. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c06915 · Cited by 1

The ADC-driven development paradigm and evolution into XDC: Current landscape and future trends

Lin, L., Zuo, C., Zhou, L., Chen, Z., Xia, Y., Kong, Z., Qi, M., Niu, M., Hou, Y., Han, H., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.08.033 · Cited by 1

Fate-informed chemistry of targeted nanomedicines: dynamic biological identity, barrier redistribution, and precision delivery

Hani, U. E., Sulaiman, M., Zafar, H., & Raza, F. (2026) · Journal of Materials Chemistry B · doi:10.1039/d6tb01950a · Cited by 1

Complexes of cell-penetrating peptides with oligonucleotides : Structure, binding and translocation in lipid membranes

Vasconcelos, F., & Daniel, L. (2017) · Cited by 1

Molecular and Genetic Therapies

Narayanaswami, P., & Živković, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-71317-7.00011-1 · Cited by 1

Solid-phase synthesis of oligouridine boranophosphates using the H-boranophosphonate method with 2′-O-(2-cyanoethoxymethyl) protection

Matsuda, H., Ito, H., Nukaga, Y., Uehara, S., Sato, K., Kuwahara, H., & Wada, T. (2021) · Tetrahedron Letters · doi:10.1016/j.tetlet.2021.153526 · Cited by 1

Fire Burn and Cauldron Bubble: What Is in Your Genome Editing Brew?

Patange, S., & Maragh, S. (2022) · Biochemistry · doi:10.1021/acs.biochem.2c00431 · Cited by 2

Guanidinium-functionalized Block Copolyelectrolyte Micelleplexes for Safe and Efficient siRNA Delivery

Heo, T.-Y., Hoang, Q. T., Cao, T. G. N., Oh, S. H., Ryu, M.-C., Shim, M. S., & Choi, S. (2022) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-022-0222-6 · Cited by 2

Modern prospects of targeted hypolipidemic therapy

Kuchmin, A. N., Борисович, Н. М., Grachev, A. M., & Смирнова, Е. В. (2023) · Bulletin of the Russian Military Medical Academy · doi:10.17816/brmma321350 · Cited by 1

The art of healing hearts: Mastering advanced RNA therapeutic techniques to shape the evolution of cardiovascular medicine in biomedical science

Hou, G., Alissa, M., Alsuwat, M. A., Alarjany, H. M. A., Alzahrani, K. J., Althobaiti, F. M., Mujalli, H. M., Alotaiby, M. M., Al-Doaiss, A. A., & Anthony, S. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102627 · Cited by 1

RNA and the emerging potential of bio-inspired molecules in cardiovascular disease therapies

Ahmed, N. T., & Davis, D. R. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae348 · Cited by 1

Small RNAs in Cancer Therapy

Pan, Y., Wang, Q., & Ma, Y. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_285 · Cited by 1

Histidine Decapeptide‐Incorporating Lipid Nanoparticles with Low Ionizable Lipids Proportion for Efficient Small Interfering RNA Delivery

Bae, Y., Lee, H., Lee, J. H., Yeo, S., & Mok, H. (2025) · Macromolecular Bioscience · doi:10.1002/mabi.202500165 · Cited by 1

Long Noncoding RNA as Novel Cancer Diagnostic and Effective Therapeutic Targets

Leucci, E. (2018) · Springer eBooks · doi:10.1007/978-981-10-8372-3_12 · Cited by 1

Rôle et potentiel thérapeutique des microARNs dans le diabète

Jacovetti, C., & Regazzi, R. (2019) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(19)30115-4 · Cited by 1

Prospective Advances in Non-coding RNAs Investigation

Jan, M. I., Ali, T., Ishtiaq, A., Mushtaq, I., & Murtaza, I. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1671-9_24 · Cited by 1

Disulfide-unit Conjugation Enables Ultrafast Cytosolic Internalization of Antisense DNA and siRNA

Nakamoto, K., Shu, Z., & Abe, H. (2020) · Journal of Synthetic Organic Chemistry Japan · doi:10.5059/yukigoseikyokaishi.78.456 · Cited by 1

Delivery of RNA Therapeutics: The Great Endosomal Escape!

Dowdy, S. F., Setten, R. L., Cui, X.-S., & Jadhav, S. G. (2022) · Nucleic Acid Therapeutics · doi:10.1089/nat.2022.0004 · Cited by 164

Different cellular barriers to RNA therapeutics and strategies to overcome

Chatterjee, S., Bhattacharya, M., Agoramoorthy, G., & Chakraborty, C. (2023) · International Journal of Surgery · doi:10.1097/js9.0000000000000090 · Cited by 2

Harnessing RNA molecules for therapy: advances in design, delivery, and clinical development

Zou, J., He, X., Li, Z., Song, B., Xing, X., Yu, J., & He, W. (2025) · Targetome · doi:10.48130/targetome-0025-0003 · Cited by 7

RNA therapeutics: updates and future potential

Zhang, C., & Zhang, B. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2171-2 · Cited by 125

Recent Advances in RNA Therapeutics and RNA Delivery Systems Based on Nanoparticles

Shin, H., Park, S. D., Yim, Y., Kim, J., Choi, C., Won, C., & Min, D. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800065 · Cited by 95